Sofosbuvir/velpatasvir for the treatment of HCV: excellent results from a phase-3, open-label study in Russia and Sweden

Author:

Isakov Vasily1ORCID,Chulanov Vladimir23,Abdurakhmanov Dzhamal3,Burnevich Eduard34,Nurmukhametova Elena5,Kozhevnikova Galina6,Gankina Natalya7,Zhuravel Sergey8,Romanova Svetlana9,Hyland Robert H.10,Lu Sophia10,Svarovskaia Evguenia S.10,McNally John10,Brainard Diana M.10,Ivashkin Vladimir3,Morozov Vyacheslav11,Bakulin Igor12,Lagging Martin13ORCID,Zhdanov Konstantin14,Weiland Ola15

Affiliation:

1. 1Department of Gastroenterology and Hepatology, Institute of Nutrition, Moscow, Russia;

2. 2Central Research Institute of Epidemiology, Moscow, Russia;

3. 3Hepatology Unit, Sechenov First State Medical University, Moscow, Russia;

4. 4City Clinical Hospital #24 of Moscow Healthcare Department, Moscow, Russia;

5. 5Clinic Tour LLC, Moscow, Russia;

6. 6Central Scientific and Research Institute of Epidemiology, Moscow, Russia;

7. 7Krasnoyarsk Regional Center of AIDS Prevention, Krasnoyarsk, Russia;

8. 8Sklifosovsky Scientific Research Institution of Emergency Care of Moscow Healthcare Department, Moscow, Russia;

9. 9Center for Prevention and Control AIDS and Infectious Diseases, Saint Petersburg, Russia;

10. 10Gilead Sciences, Foster City, CA, USA;

11. 11Hepatolog LLC, Samara, Russia;

12. 12Propedeutics of Internal Diseases, Gastroenterology and Dietology, I.I. Mechnikov North-West State Medical University, Saint Petersburg, Russia;

13. 13Department of Infectious Diseases/Virology, Institute of Biomedicine Sahlgrenska Academy University of Gothenburg, Gothenburg, Sweden;

14. 14Kirov Medical Military Academy, Saint Petersburg, Russia;

15. 15Department of Internaö Medicine Division of Infectious Diseases, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden

Funder

Gilead Sciences

Gilead Sciences Inc.

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3